Safety and biodistribution of exosomes derived from human induced pluripotent stem cells

As a new cell-free therapy, exosomes have provided new ideas for the treatment of various diseases. Human induced pluripotent stem cells (hiPSCs) cannot be used in clinical trials because of tumorigenicity, but the exosomes derived from hiPSCs may combine the advantages of iPSC pluripotency and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zhewei, Yin, Zhiyu, Song, Pengbo, Wu, Ying, He, Ying, Zhu, Maoshu, Wu, Zhengxin, Zhao, Sicheng, Huang, Hongri, Wang, Huihuang, Tong, Cailing, Qi, Zhongquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461140/
https://www.ncbi.nlm.nih.gov/pubmed/36091443
http://dx.doi.org/10.3389/fbioe.2022.949724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461140/
https://www.ncbi.nlm.nih.gov/pubmed/36091443
http://dx.doi.org/10.3389/fbioe.2022.949724

Ejemplares similares